Neuromuscular disorders : NMD · 2010
Myopathy with hexagonally cross-linked crystalloid inclusions: delineation of a clinico-pathological entity.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Claeys Kristl G, Pellissier Jean-François, Garcia-Bragado Federico, Weis Joachim, Urtizberea Andoni, Poza Juan-Jose, Cobo Ana-Maria, Stoltenburg Gisela, Figarella-Branger Dominique, Willems Patrick J, Depuydt Christophe E, Kleiner Wolfgang, Pouget Jean, Piraud Monique, Brochier Guy, Romero Norma B, Fardeau Michel, Goebel Hans H, Bönnemann Carsten G, Voit Thomas, Eymard Bruno, Laforêt Pascal
Аннотация
A novel myopathy characterized by hexagonally cross-linked tubular arrays has been reported in five patients. We studied the clinical and histopathological features of five additional unrelated patients with this myopathy. Patients experienced exercise intolerance with exercise-induced myalgia and weakness, without rhabdomyolysis. One patient additionally presented mild permanent pelvic girdle muscle weakness. Age at onset varied between 13 and 56 years. The inclusions were eosinophilic on H and E, bright red with modified Gomori's trichrome stains, present in type 2 fibers, and revealed immunoreactivity selectively for a caveolin-3-antibody. Ultrastructurally, the inclusions showed a highly organized, hexagonally cross-linked crystalloid structure. Mutations in the caveolin-3 encoding gene were excluded. Biochemical assessment of glycogenolysis in muscle was normal. Inherited or sporadic myopathy with hexagonally cross-linked tubular arrays is associated with a homogeneous clinical and histopathological phenotype. This myopathy should be included in the differential diagnosis of patients with exercise intolerance and myalgia.